Exam 1 Review Flashcards
Based on my opinion of what her prompts mean
SSRIs for PTSD?
SSRIs are approved as a first-line treatment of PTSD.
A 51-year-old male veteran with chronic PTSD has agreed to begin pharmacotherapy for his debilitating symptoms of arousal and anxiety associated with his experiences in Iraq 2 years ago. Which of the following would be appropriate as first-line treatment?
-Paroxetine, lorazepam, d-cycloserine, or quetiapine
-Paroxetine, lorazepam, d-cycloserine
-Paroxetine
-Paroxetine or lorazepam
Paroxetine, a selective serotonin reuptake inhibitor (SSRI), is approved for use in PTSD. The SSRI sertraline is also approved for PTSD. Lorazepam is a benzodiazepine. Benzodiazepines do not have
evidence of efficacy in PTSD and are not generally recommended for first-line use in PTSD. d-cycloserine, an N-methyl-d-aspartate (NMDA) agonist, has been theorized to be useful in facilitating fear extinction, and may be useful in conjunction with exposure therapy. However, it is not a first-line choice. Quetiapine, an atypical antipsychotic, is not approved as first-line treatment for PTSD but may be useful
in selected cases as a third-line treatment, specifically for sleep and possible reduction of nightmares.
A 38-year-old man with a history of treatment-resistant PTSD has now experienced improvement on quetiapine 300 mg/day, duloxetine 90 mg/day, and zolpidem 10 mg at bedtime. However, he complains of ongoing nightmares and difficulty staying asleep. He was previously initiated on prazosin 3 mg at bedtime, but he experienced intolerable dizziness, and it was discontinued. Can this patient be rechallenged with prazosin? If so, at what dose?
-No; prazosin is contraindicated with quetiapine
-Yes; dose should be initiated at 3 mg at bedtime
-No; prazosin should not be reattempted in patients with previous intolerability
-Yes; dose should be initiated at 1 mg at bedtime
Yes; dose should be initiated at 1 mg at bedtime. Prazosin, an alpha 1 antagonist, can be an effective treatment for nightmares in PTSD. The initial dose of prazosin should be 1 mg at bedtime and titrated up 1 mg every 2–3 days to decrease the risk of syncope and Orthostatic Hypotension.
SSRIs (list drugs)
Citalopram
Escitalopram
Paroxetine
Sertraline
Fluoxetine
Fluvoxamine
Fluvoxamine (prescriber notes)
Brand name: Luvox
used mostly for OCD
SSRI
OCD treatment
SSRIs for first-line pharma tx (start at half dose IF: elderly/worried about adverse effects/comorbid GAD)
CBT first-line therapy
Clomipramine is second-line
Other meds: Venlafaxine, Pindolol, Phenelzine, Buspirone, 5-HT, L-Tryptophan, Clonazepam, and Risperidone
OCD diagnosis
To meet criteria: either obsessions or compulsions that take up more than 1 hour per day or significantly interfere with normal functioning
Obsessions: intrusive, inappropriate, recurrent and persistent thoughts that cause marked anxiety and distress
Compulsions: repetitive behaviors or mental acts done by the individual in response to the obsession or according to rules that must be rigidly applied
Criteria for PTSD diagnosis
-Exposure to actual or threatened death, serious injury, or sexual violence
-1 or more intrusion symptoms (e.g., distressing memories/dreams, reliving experience)
-Persistent efforts to avoid trauma stimuli
-2 or more persistent negative alterations in cognitions and mood
-2 or more marked alterations in arousal and reactivity
Symptoms present for 1 month or longer, cause sign clinical distress or impairment in area of functioning, not caused by substance or other underlying medical condition
What medications could be used to augment OCD treatment?
Mood stabilizers (valproate, lithium, carbamazepine)
Cataplexy
A sudden, brief loss of voluntary muscle tone triggered by strong emotions such as laughter, excitement, anger or fear. There is a strong association between cataplexy and narcolepsy
Sodium Oxybate
A medication that improves nighttime sleep architecture and reduces excessive daytime sleepiness (EDS) and cataplexy in narcolepsy by modulating GABA receptors.
Valporic acid treatment precautions
Valproic acid = Valproate = Depakote
Adverse effects include pancytopenia (thrombocytopenia) and liver toxicity
Order complete blood count (CBC) and liver function labs before starting Valproic acid/Depakote
What laboratory parameter should be closely monitored to prevent the development of thrombocytopenia in a patient on Valproic Acid therapy?
-Platelet count
-White blood cell count
-Serum creatinine levels
-Serum albumin levels
Valproic Acid can lead to a decrease in platelet count, a condition known as thrombocytopenia. Monitoring platelet count is crucial to detect this side effect early and prevent complications such as
bleeding.
Lamotrigine (Lamictal) adverse effects
Can cause life-threatening rash (Steven Johnson Syndrome Rash also known as toxic epidermal necrolysis); minimize risk by very slow up-titration
Avoid interactions with valproate as they raise lamotrigine levels
Educate patients to look out for rashes daily and if rash is developed contact doctor and stop lamotrigine immediately, seek immediate care
Which of the following symptoms should be closely monitored during the initiation of Lamotrigine therapy?
-Dry mouth
-Skin rashes
-Increased appetite
-Muscle weakness
Lamotrigine is associated with a risk of severe skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Patients should be closely monitored for any signs of skin rash, especially during the initial weeks of treatment.
How often should patients be monitored for potential skin rashes during the titration phase of Lamotrigine treatment?
-Monthly
-Daily
-Weekly
-Every 3 months
Daily. During the titration phase of Lamotrigine treatment, patients should be monitored for potential skin rashes on a daily basis. Skin reactions, if they occur, often appear early in treatment. Close monitoring allows for prompt intervention in case of any rash development, which is important to prevent the progression of severe skin reactions.
A woman in her 20th week of pregnancy has been resumed on lithium for bipolar disorder. The PMHNP knows that the patient may become subtherapeutic despite taking the medication as prescribed due to:
Increased blood volume occurs as pregnancy progresses and patients may need higher doses of medication to maintain concentration effects. Fetal metabolism has no impact on maternal metabolism, but caution is exercised for potential adverse effects to the fetus. Pregnant women do not have decreased muscle mass or reduced blood volume.
Sertraline (prescriber notes)
Brand name: Zoloft
Best tolerated, best choice for pregnancy
SSRI
A patient with schizophrenia was discharged from the hospital on olanzapine 5 mg twice a day. He immediately resumed smoking cigarettes and escalated to one pack per day. Upon presenting for his 1-week follow-up appointment, the patient reports he is having trouble sleeping and the voices have started to return. Which of the following actions should the PMHNP take?
- increase his olanzapine and schedule a FU visit in 2 days
- send the patient to the ED for stabilization
- change to another antipsychotic med and refer to psychiatrist
- tell him to stop smoking and give him a nicotine patch
Increase his olanzapine and schedule a follow up visit because the patient’s symptoms are no longer controlled and smoking is a known inducer of the CYP450 pathway. The patient has not indicated a threat of harm to self or others; changing to another antipsychotic
medication requires re-titration and is not indicated. Telling a patient to stop smoking may trigger a psychological paradox and can erode
therapeutic alliance.
Bupropion
Brand name: Wellbutrin
NE and DA reuptake inhibitor
Appropriate first-line treatment for MDD
Can be used to augment (usually SSRI)
Can be used for smoking cessation and ADHD
Dose in the morning
CYP450 1A2 Inducers
Smoking (can affect the metabolism of antipsychotics like clozapine and olanzapine)
Rifampin (antibiotic)
Carbamazepine (anticonvulsant, mood stabilizer)
When explaining the means by which neurotransmitters relate to mental illness, a patient asks, “What is a neurotransmitter?” The best answer is:
-The space between nerve cells
-A fatty layer covering the axon
-A chemical messenger
-A nerve cell
A neurotransmitter is a chemical messenger, created from dietary substrates, that transmits information between neurons.
DSM-5 Criteria for MDD (unipolar depression)
5 or more of the following symptoms (including at least 1 depressed mood and loss of interest or pleasure) in the same 2-week period; each of these represents a change from previous functioning:
-Depressed mood (subjective or observed)
-Loss of interest or pleasure
-Change in weight or appetite
-Insomnia or hypersomnia
-Psychomotor retardation or agitation (observed)
-Loss of energy or fatigue
-Worthless or guilt
-Impaired concentration or indecisiveness
-Thoughts of death or suicidal ideation or suicide attempt
Major Depressive Disorder SIGECAPS
Sleep
Interest
Guilt
Energy
Concentration
Appetite
Psychomotor Agitation/Retardation
Suicide
5 or more of the above symptoms must be present within a 2 week time period to diagnose.
Symptoms MUST interfere with social, occupational, OR interpersonal functioning.
Cannot be accounted for by another psychiatric disorder.
No past manic or hypomanic episodes
(Mania = at least 7 days; Hypomania = at least 4 days)
Underlying Bipolar? DIGFAST
Distractibility
Indiscretion
Grandiosity
Flight of Ideas
Activities Increase
Sleep Deficit
Talkativeness
-If having these ^ symptoms in response to antidepressant treatment (or in general), may indicate underlying bipolar disorder
First line treatments for MDD
SSRIs, SNRIs, Bupropion (Wellbutrin), Mirtazapine (Remeron)
Margaret is a 42-year-old patient with untreated depression. She is reluctant to begin antidepressant treatment due to concerns about treatment-induced weight gain. Which of the following antidepressant treatments is associated with the greatest risk of weight gain?
-Vilazodone
-Mirtazapine
-Fluoxetine
-Escitalopram
Mirtazapine. Meta-analysis has shown that mirtazapine, an alpha 2 antagonist, may cause both short- and long-term weight gain. This is consistent with its secondary pharmacological properties: mirtazapine is an antagonist at both serotonin 2C and histamine 1 receptors, the combination of which has been proposed to cause weight gain. However, it should be noted that average weight gain with any antidepressant is small, and rather than a widespread effect it may instead be that a small number of individuals experience significant weight gain due to their genetic predispositions and other factors.
Adverse effects of SSRIs
-Transient = nausea, bowel changes, headaches, fatigue, agitation
-Sexual (up to 75% incidence)
-Serotonin syndrome/toxicity
Serotonin Syndrome (Serotonin Toxicity)
Start with and escalates to :
1)Diarrhea/restlessness
2)Mydriasis (dilated pupils), Diaphoresis, HTN, tachycardia
3)Extreme agitation, tremor, rigidity, increased reflexes
4)Autonomic instability, hyperthermia, delirium, seizures
5)coma, respiratory failure, renal failure, death
Educate patient on early signs and when to call office
Escitalopram (prescriber notes)
Brand name: Lexapro
Fewest adverse effects
SSRI
Fluoxetine (prescriber notes)
Brand name: Prozac
Best for children 8+ and adolescents; longest half-life; can give weak dose (90mg once weekly after starting on daily dose); good for forgetful/noncompliant patients
SSRI